ALLOSTERIS Trademark

Trademark Overview


On Tuesday, December 10, 2024, a trademark application was filed for ALLOSTERIS with the United States Patent and Trademark Office. The USPTO has given the ALLOSTERIS trademark a serial number of 98895371. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 16, 2025. This trademark is owned by VIB VZW. The ALLOSTERIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

(Based on 44(e) Priority Application) Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substances, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory syst...

Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, biotechnology, biomedicine, veterinary science and industrial biotechnology; natural science services, namely, scientific and medical research; clinical research in the fields of cardiovascular diseases, allergies, autoimmune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases; clinical research in the fields of medical and biotechnological procedures, namely, radiology, chemotherapy and in vivo imaging; medical research laboratories; conducting evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug discovery services; pharmaceutical drug development services; research and development in the field of biotechnology; providing a web hosting platform for biotechnological research
allosteris

General Information


Serial Number98895371
Word MarkALLOSTERIS
Filing DateTuesday, December 10, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2025

Trademark Statements


Goods and Services(Based on 44(e) Priority Application) Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substances, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; (Based on Intent To Use); Medical preparations and substances, namely, fungal preparations in the nature of fungal medications for medical purposes, probiotic preparations for medical use, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations in the nature of veterinary pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Biologicals preparations for pharmaceutical, medical and veterinary use, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Diagnostic and therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, diagnostic preparations for veterinary and medical use, pharmaceutical preparations and biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Preparations and substances for use in drug discovery, namely, preparations for growing cells or for producing biologicals for medical, pharmaceutical, and veterinary purposes, and reagents and media for medical, pharmaceutical and veterinary diagnostic purposes, namely, media and reagents serving as inoculate, clinical medical reagents, and diagnostic reagents
Goods and ServicesScience and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, biotechnology, biomedicine, veterinary science and industrial biotechnology; natural science services, namely, scientific and medical research; clinical research in the fields of cardiovascular diseases, allergies, autoimmune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases; clinical research in the fields of medical and biotechnological procedures, namely, radiology, chemotherapy and in vivo imaging; medical research laboratories; conducting evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug discovery services; pharmaceutical drug development services; research and development in the field of biotechnology; providing a web hosting platform for biotechnological research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVIB VZW
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGent 9052
BE

Party NameVIB VZW
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGent 9052
BE

Trademark Events


Event DateEvent Description
Tuesday, December 10, 2024NEW APPLICATION ENTERED
Sunday, April 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 3, 2025NON-FINAL ACTION E-MAILED
Friday, August 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 18, 2025EXAMINERS AMENDMENT E-MAILED
Monday, August 18, 2025EXAMINER'S AMENDMENT ENTERED
Monday, August 18, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, August 18, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 29, 2025ASSIGNED TO EXAMINER
Tuesday, June 3, 2025NON-FINAL ACTION WRITTEN